Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.48 |
| ▸ | TK1 | P04183 | 2/20 | 0.45 |
| ▸ | PNP | P00491 | 3/20 | 0.43 |
| ▸ | BLM | P54132 | 2/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | EDNRA | P25101 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | HBB | P68871 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | VCP | P55072 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL442295 | 0.88 | ADORA3 (0.48) | ADORA3TK1PNPBLMUSP2 | |
| SCHEMBL27745728 | 0.88 | ADORA3 (0.48) | ADORA3TK1PNPBLMUSP2 | |
| SCHEMBL30822753 | 0.87 | ADORA3 (0.48) | ADORA3TK1PNPBLMUSP2 | |
| SCHEMBL3148834 | 0.87 | ADORA3 (0.48) | ADORA3TK1PNPBLMUSP2 | |
| SCHEMBL9489893 | 0.87 | ADORA3 (0.48) | ADORA3TK1PNPBLMUSP2 | |
| SCHEMBL3501828 | 0.87 | ADORA3 (0.48) | ADORA3TK1PNPBLMUSP2 | |
| SCHEMBL28874867 | 0.87 | ADORA3 (0.52) | ADORA3TK1PNPBLMUSP2 | |
| SCHEMBL442605 | 0.87 | ADORA3 (0.48) | ADORA3TK1PNPBLMUSP2 | |
| SCHEMBL31392666 | 0.87 | ADORA3 (0.48) | ADORA3TK1PNPBLMUSP2 | |
| SCHEMBL3503652 | 0.87 | ADORA3 (0.48) | ADORA3TK1PNPBLMUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025024123-A1 | NOVEL CITICOLINE DERIVATIVES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-30 | — | — | WO | claimed |
| CN-120918189-B | Application of small molecular compound in preventing and treating plant RNA virus infection | 宁波大学 | 2026-04-28 | — | — | CN | disclosed |
| EP-4652277-A1 | POLYNUCLEOTIDE COMPOSITIONS AND METHODS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | Aptah Bio, Inc. (US) | 2025-11-26 | — | — | EP | disclosed |
| EP-4652278-A1 | POLYNUCLEOTIDE COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER | Aptah Bio, Inc. (US) | 2025-11-26 | — | — | EP | disclosed |
| CN-120918189-A | Application of small molecular compound in preventing and treating plant RNA virus infection | 宁波大学 | 2025-11-11 | — | — | CN | disclosed |
| WO-2025024123-A1 | NOVEL CITICOLINE DERIVATIVES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-30 | — | — | WO | disclosed |
| WO-2024155740-A1 | POLYNUCLEOTIDE COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER | APTAH BIO, INC. (US) | 2024-07-25 | — | — | WO | disclosed |
| WO-2024155739-A1 | POLYNUCLEOTIDE COMPOSITIONS AND METHODS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | APTAH BIO, INC. (US) | 2024-07-25 | — | — | WO | disclosed |
| WO-2024137991-A2 | ENGINEERED GUIDE RNAS AND POLYNUCLEOTIDES | SHAPE THERAPEUTICS INC. (US) | 2024-06-27 | — | — | WO | disclosed |
| CN-117751190-A | Compositions and methods for modulating SOS gene expression | 美国微哲默理有限责任公司 | 2024-03-22 | — | — | CN | disclosed |
| EP-4158018-A1 | COMPOSITIONS AND METHODS FOR GENOME EDITING | Shape Therapeutics Inc. (US) | 2023-04-05 | — | — | EP | disclosed |
| WO-2022269346-A2 | COMPOSITIONS AND METHODS OF MODULATING XANTHINE DEHYDROGENASE | HORIZON THERAPEUTICS IRELAND DAC (IE) | 2022-12-29 | — | — | WO | disclosed |
| CN-115023503-A | Method for producing closed linear DNA | 泰瑞斯疗法公司 | 2022-09-06 | — | — | CN | disclosed |
| CN-115003829-A | Closed linear DNA with modified nucleotides | 泰瑞斯疗法公司 | 2022-09-02 | — | — | CN | disclosed |
| WO-2022103839-A1 | RNA EDITING COMPOSITIONS AND USES THEREOF | SHAPE THERAPEUTICS INC. (US) | 2022-05-19 | — | — | WO | disclosed |
| CN-114381470-A | Artificial nucleic acid molecules | 库瑞瓦格股份公司 | 2022-04-22 | — | — | CN | disclosed |
| EP-3108010-A1 | SAMPLE PREPARATION METHOD | Oxford Nanopore Technologies Limited (GB) | 2016-12-28 | — | — | EP | disclosed |
| WO-2015124935-A1 | SAMPLE PREPARATION METHOD | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2015-08-27 | — | — | WO | disclosed |
| WO-1999020753-A2 | PEPTIDE BOND FORMATION USING NUCLEIC ACID CATALYSTS | RIBOZYME PHARMACEUTICALS, INC. (US) | 1999-04-29 | — | — | WO | disclosed |
| EP-0381335-A1 | Antiviral agent and novel nucleoside | TANABE SEIYAKU CO., LTD. (JP) | 1990-08-08 | — | — | EP | disclosed |